# abrdn Life Sciences Investors: Form SCHEDULE 13D/A, filed Feb 11, 2026

- Company: [abrdn Life Sciences Investors](/companies/hql.md) (CIK 884121)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-11
- Accepted by EDGAR: Feb 11, 2026, 23:53 ET
- Period: not reported
- Accession: 0001062993-26-000816
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/884121/000106299326000816/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884121/000106299326000816/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/884121/000106299326000816/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001062993-26-000816. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.